Facebook
Twitter
Telegram
Report an ErrorAlpine Immune Sciences Financial Ratios 2011-2024 | ALPN
Annual Financial Ratios Alpine Immune Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.7 | -4.2 | -8.7 | -1.3 | -2.5 | -9.2 | -1.1 | -1.9 | - | - | - | - |
P/S |
8.9 | 9.0 | 26.1 | 31.5 | 130.6 | 41.5 | - | - | - | - | - | - |
EPS |
-1.7 | -2.0 | -1.3 | -2.3 | -2.6 | -1.2 | -2.0 | -2.4 | -20.3 | -104.5 | - | - |
EV (Enterprise Value) |
363 M | 277 M | 291 M | 63.4 M | 91.7 M | 70.2 M | 15.9 M | 23.4 M | 16.5 M | 94.3 M | - | - |
EBITDA per Share |
-1.72 | -1.93 | -1.35 | -2.35 | -2.62 | -2.27 | -8.2 | -9.75 | - | - | - | - |
EV/EBITDA |
-5.5 | -10.0 | -1.0 | -2.4 | -4.7 | -0.3 | -0.8 | - | - | - | - | |
PEG |
4.18 | 0.31 | 0.35 | -0.1 | 0.02 | -0.11 | -0.06 | 0.07 | - | - | - | - |
P/B |
1.5 | 1.7 | 3.9 | 1.9 | 2.1 | 0.9 | 0.6 | 0.5 | - | - | - | - |
P/CF |
-6.1 | -13.8 | 8.1 | -1.5 | -3.2 | -4.2 | -1.3 | -2.3 | - | - | - | - |
ROE % |
-32.19 | -41.63 | -44.95 | -142.00 | -81.83 | -9.86 | -56.76 | -27.33 | - | - | - | - |
ROA % |
-20.15 | -19.67 | -19.39 | -77.37 | -66.49 | -9.13 | -50.80 | -25.96 | - | - | - | - |
ROCE % |
-32.41 | -41.24 | -46.25 | -95.95 | -78.35 | -17.97 | -57.55 | -27.43 | - | - | - | - |
Current Ratio |
2.7 | 1.9 | 1.8 | 4.9 | 6.6 | 43.6 | 9.5 | 19.8 | - | - | - | - |
DSO |
154.1 | 194.6 | - | 143.9 | 122.7 | 27.0 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
154.1 | 194.6 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
154.1 | 194.6 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Alpine Immune Sciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.28 | - | -0.24 | -0.27 | -0.28 | - | -0.42 | -0.6 | -0.25 | - | -0.55 | -0.46 | -0.45 | - | -0.28 | -0.53 | -0.3 | - | -0.62 | -0.64 | -0.7 | - | -0.88 | -0.57 | -0.38 | - | 0.2 | -5.4 | -3.23 | -0.5 | -0.61 | -0.55 | -0.51 | -0.42 | -0.39 | -1.41 | -1.95 | -1.58 | -7.68 | -25.7 | -27.02 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.35 | - | - | - | -0.32 | - | -0.42 | -0.53 | -0.24 | - | -0.52 | -0.44 | -0.43 | - | -0.29 | -0.51 | -0.29 | - | -0.61 | -0.64 | -0.7 | - | -0.87 | -0.6 | -0.4 | - | -0.41 | -5.31 | -3.16 | -503 | -0.58 | -0.55 | -0.51 | -429 | -0.39 | -1.4 | -1.95 | -1.58 K | -7.53 | -23.9 | -27.3 K | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-27.66 | -22.84 | -30.14 | -30.18 | -40.59 | -32.00 | -42.98 | -46.68 | -53.66 | -56.12 | -65.99 | -64.88 | -55.69 | -34.75 | -73.68 | -102.74 | -126.99 | -121.16 | -148.39 | -136.68 | -114.18 | -56.85 | -54.17 | -24.25 | -11.08 | -4.39 | 524.98 | 547.97 | 537.23 | 525.61 | -11.63 | -44.59 | -36.30 | -27.33 | 2.66 | 26.67 | 60.27 | 65.44 | 43.31 | 26.59 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-19.74 | -15.14 | -19.69 | -19.37 | -22.55 | -16.15 | -21.93 | -23.16 | -21.68 | -20.87 | -25.13 | -23.61 | -23.60 | -14.99 | -36.20 | -53.16 | -68.18 | -66.02 | -88.14 | -89.05 | -81.54 | -46.20 | -43.71 | -19.10 | -8.91 | -4.07 | -65.30 | -70.76 | -80.23 | -90.55 | -36.78 | -40.74 | -33.70 | -25.96 | -30.70 | -33.00 | -41.02 | -36.11 | -23.90 | -14.68 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-34.07 | -27.44 | -35.04 | -33.64 | -40.96 | -30.63 | -41.42 | -44.62 | -52.54 | -54.96 | -66.18 | -66.59 | -57.80 | -35.86 | -75.59 | -104.10 | -129.64 | -124.03 | -151.81 | -139.86 | -117.49 | -59.17 | -64.94 | -42.94 | -28.67 | -12.91 | 524.09 | 556.01 | 545.11 | 533.33 | -11.61 | -45.07 | -36.57 | -27.43 | 2.65 | 26.80 | 58.93 | 64.10 | 41.97 | 25.12 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
9.1 | 7.3 | 3.0 | 3.0 | 2.8 | 2.7 | 2.7 | 1.9 | 2.0 | 1.9 | 2.1 | 1.4 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 2.2 | 2.2 | 2.2 | 2.2 | 5.3 | 5.3 | 5.3 | 5.3 | 13.5 | 13.5 | 13.5 | 13.5 | 5.0 | 5.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
1.4 | - | 2.3 | 5.0 | 5.2 | - | 9.3 | 12.5 | 84.1 | - | 242.9 | 287.6 | - | - | 1260.9 | 315.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
1.4 | - | 2.3 | 5.0 | 5.2 | - | 9.3 | 12.5 | 84.1 | - | 242.9 | 287.6 | - | - | 1260.9 | 315.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
1.4 | - | 2.3 | 5.0 | 5.2 | - | 9.3 | 12.5 | 84.1 | - | 242.9 | 287.6 | - | - | 1260.9 | 315.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency